press release investor Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024 Nov 12, 2024 12:00:00 AM
press release investor Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering Nov 11, 2024 12:00:00 AM
press clippings With NREL's Help, GCxN Company Readies for Initial Public Offering Sep 30, 2024 12:00:00 AM
biofuel investor science NREL (DoE) working with Invizyne in their 'Advancing Clean Tech to Energize the Future' project - a fireside chat Aug 2, 2024 12:00:00 AM
investor video Commercializing Invizyne’s cell-free platform - fireside chat with Zachary Karl, PhD, VP of BizDev - and - Lou Basenese Jul 30, 2024 12:00:00 AM
investor video Invizyne IPO: interview with Dr. James J. Lalonde by MDB Capital President and Chief Market Strategist Lou Basenese Jul 17, 2024 12:00:00 AM
press release investor MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies Jul 11, 2024 12:00:00 AM
investor video CEO Michael Heltzen and Co-Founder & VP of Research Dr. Tyler Korman present the Invizyne story and IPO opportunity to investors Jun 18, 2024 12:00:00 AM
investor video MDB Capital CEO and Invizyne board member, Chris Marlett, presents the Invizyne story and initial public offering (IPO) opportunity to investors via Zoom on June 11, 2024 Jun 11, 2024 12:00:00 AM
video science The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth May 22, 2024 12:45:00 AM
